The in vivo Anti‐tumor Effect of Human Recombinant Interleukin‐6

Administration of recombinant interleukin‐6 (IL‐6) was found to induce in vivo generation of cytotoxic T lymphocytes (CTL) against syngeneic transplantable erythroleukemia (FBL‐3) in lymph node cells and peritoneal exudate cells (PEC) in C57BL/6 mice. Furthermore, 15 out of 16 C57BL/6 mice injected...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Jpn J Cancer Res
Asıl Yazarlar: Kitahara, Misa, Kishimoto, Susumu, Hirano, Toshio, Kishimoto, Tadamitsu, Okada, Masaji
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Blackwell Publishing Ltd 1990
Konular:
Regular Papers
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5917969/
https://ncbi.nlm.nih.gov/pubmed/2121676
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.1990.tb03342.x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller